To observe the effect of Rhein lysinate (RHL) on cellular senescence of human umbilical vascular endothelial cells (HUVECs) and elucidate its action mechanism. Methods: Cell viability was determined using MTT assay. The expression levels of Sirt1 mRNA and protein were measured by RT-PCR and Western blot, respectively. Senescence associated (SA)-β-galactosidase activity was detected to evaluate cell senescence. Apoptosis and cell cycle progression were determined using flow cytometry. INK4a .
Introduction
Aging is considered to be a major risk factor for developing atherosclerosis and is also associated with reducing the regenerative capacity of the endothelium and causing endothelial senescence [1] . Atherosclerosis is a very common condition associated with increased cardiovascular risk, and endothelial dysfunction is thought to promote its development [2] . However, the underlying mechanisms remain to be determined. Moreover, atherosclerosis is also associated with an increase in endothelial cell turnover, and endothelial cell apoptosis plays a pivotal role in developing atherosclerotic plaques [3] . The silent information regulator 2 (Sir2) is an NAD-dependent deacetylase. It is well known that an overexpression of Sir2, or its homologue, can extend the lifespan of a wide range of lower eukaryotes, including yeasts, worms and flies [4] . In mammals, Sir2 is represented by seven homologues (Sirt1~7), of which Sirt1 is the most closely related to the yeast Sir2 and has been studied extensively.
Recent studies have demonstrated that Sirt1 plays an important role in regulating cell survival by inhibiting apoptosis induced by stress [5] [6] [7] . Researchers speculate that Sirt1 could also regulate cell aging because it has been reported that apoptosis and senescence in vascular endothelial cells are closely related to atherosclerosis progression.
In this study, we investigated the ability of Sirt1 to interfere with apoptosis and cellular senescence in human umbilical vascular endothelial cells (HUVECs) one of the major bioactive constituents of the rhubarb rhizome (R palmatum L or R tanguticum Maxim) [8] . In previous studies, Rhein was found to have a variety of bioactivities, such as inhibiting IL-1 induced chondrocyte activation [9] , decreasing hypertrophy in mesangial cells [10] , inhibiting tumor cell proliferation, and inducing tumor cell apoptosis [11] . In our previous study, we also found that a dose of more than 20 µmol/L RHL could inhibit tumor cell proliferation, and it acted synergistically with Taxol when combined, both in vitro and in vivo [12] . However, less than 20 µmol/L RHL can also improve cell viability. Therefore, we investigated the effect of RHL on cell viability in HUVECs and explored its mechanisms.
Materials and methods
Reagents RHL, the salt of Rhein and lysine, was made in our department with 95% purity. Its structural formula was shown in our previous article. Gelatin, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), collagenase I, and heparin were obtained from Sigma Aldrich (Shanghai, China); endothelial cell growth factor (ECGF) was purchased from Roche (Shanghai, China); and trypsin was purchased from Gibco (Grand Island, NY, USA). Sirt1 and acetyl-p53 (lys382) antibody were purchased from Upstate (New York, USA); antibodies against p53, p21, p16
INK4a , Bcl-2, Bax, and β-Actin were purchased from Santa Cruz Technology (Santa Cruz, CA, USA); and secondary antibodies against rabbit or mouse were purchased from Cell Signaling Technology (Danvers, MA, USA). Pre-stained Protein Marker p7708V was purchased from New England Biolabs Ltd (Pickering, Ontario, Canada). Western Blotting Luminol Reagent and PVDF membrane were purchased from Millipore (Billerica, MA, USA).
Cell culture and determining cell viability HUVECs isolated from newborn umbilical cord were grown in M199 supplemented with 20% fetal bovine serum (FBS) (Hyclone, Logan, UT, USA) at 37 °C under 5% CO 2 in a humidified atmosphere. Cells were incubated with different concentrations of RHL (0, 5, 10, 15, and 20 μmol/L) at 37 °C for 48 h. Moreover cells were incubated with 10 μmol/L RHL for 0, 6, 12, 24, and 48 h. Cell viability was assessed by MTT method.
Reverse transcription-PCR
The mRNA level of Sirt1 in HUVECs was measured by RT-PCR. Total RNA in HUVECs was isolated with TRIzol (Invitrogen, Carlsbad, CA, USA). After treatment with Rnase-free Dnase for 30 min, the total RNA (50 ng/μL) was reverse transcribed with oligo d(T) primers. The Sirt1 transcription level relative to GAPDH was determined by means of RT-PCR. The following primers were used: Sirt1 forward (F) 5'-CCTGACTTCAGATCAAGAGACGGT-3', reverse (R) 5'-CTGATTAAAAATGTCTCCACGAAC AG-3'; GAPDH F 5'-ACCACAGTCCATGCCATCAC-3', R 5'-TCCACCAC-CCTGTTGCTGTA-3' [13] . Amplification was performed on an Eppendorf thermocycler for 30 cycles with denaturing at 94 °C for 30 s, annealing at 58 °C for 40 s, and extension at 72 °C for 1.5 min.
Immunoblot analysis
Cells were lysed on ice for 30 min in lysis buffer [50 mmol/L HCl, pH 7.6, 150 mmol/L NaCl, 1% NP-40, 0.1% sodium dodecyl sulfate (SDS), 1 mmol/L dithiothreitol, 1 mmol/L sodium vanadate, 1 mmol/L phenylmethylsulfonyl fluoride, 10 µg/ mL aprotinin, 10 µg/mL leupeptin, and 10 mmol/L sodium fluoride]. Equal amounts of protein were separated by SDSpolyacrylamide gel electrophoresis and then transferred to nitrocellulose filters. First, the membrane was inoculated in a blocking buffer containing BSA (1%) and Tween 20 (0.1%, v/v) in PBS (PBS/Tween 20) at room temperature for 1 h. Then, it was inoculated overnight at 4 °C with the proper primary antibodies. Finally, it was inoculated with the proper secondary antibodies at room temperature for 2 h. Each membrane was developed using an enhanced ChemiImager5500 chemiluminescence system (Alpha Innotech Corporation, Miami, FL, USA).
RNA interference
Synthetic Sirt1 small interfering RNA (siRNA) was purchased from GenePharma Co, Ltd (Shanghai, China). The 21-nt siRNA sequence targeting Sirt1 corresponded to the coding region 5'-GCAACAGCAUCUUGCCUGAUUUGUA-3' and 5'-UACAAAUCAGGCAAGAUGCUGUUGC-3'. The scrambled control siRNA sequences were 5'-UUCUCCGAACGUGU-CACGUTT-3' and 5'-ACGUGACACGUUCGGAGAATT-3'. After 10 μmol/L RHL treatment for 24 h, these siRNA were transfected into HUVECs using the HiPerFect Transfection Reagent (QIAGEN, Shanghai, China). After siRNA transfection for 24 h, the cells were incubated with 100 μmol/L H 2 O 2 for 6 d. Then, the cells were stained using galactosidase (β-gal).
Galactosidase (β-gal) staining HUVECs were treated with or without different concentrations of H 2 O 2 , RHL or H 2 O 2 plus RHL. After that, the cells were washed twice with phosphate-buffered saline (PBS) and then fixed for 5 min with PBS containing 2% formaldehyde and 0.2% glutaraldehyde. The cells were then incubated at 37 °C for 10 h with a staining solution (40 mmol/L citric acid, sodium phosphate, pH 6.0, 1 mg/mL 5-bromo-4-chloro-3-isolyl-β-D-galactoside (X-gal, sigma), 5 mmol/L potassium ferrocyanide, 5 mmol/L potassium ferricyanide, 150 mmol/L NaCl, and 2 mmol/L MgCl 2 ). Senescence-associated (SA)-β-gal-positive cells were observed by microscopy, and over 400 cells were counted in three independent fields [14] .
Annexin V FITC/PI assay Annexin V-FITC/PI double staining was achieved using an Annexin V-FITC/PI apoptosis detection kit. • The Annexin V-FITC -/PI -population reflects normal healthy cells.
• The Annexin V-FITC + /PI -cells show early apoptosis.
• The Annexin V-FITC + /PI + cells are in late apoptosis or necrosis.
• The Annexin V-FITC -/PI + cells are necrotic.
• The percentage of normal, early apoptotic, late apoptotic, and necrotic cells were calculated using FACS Calibur and Cell Quest software (Becton-Dickinson, Franklin Lakes, NJ, USA) [15] . 
Cell cycle assay

Statistical analysis
Statistical analysis was performed between the control group and the different treatment groups. Comparisons of the means were conducted by one-way ANOVA. All values were expressed as the mean±SD, and P<0.05 was considered to be statistically significant.
Results
Low levels of RHL improve HUVEC proliferation and enhance Sirt1 transcription and expression Our previous study indicated that low levels of RHL (less than 20 μmol/L) could improve cell proliferation in MCF-7 breast cancer cells. The same effect of RHL on HUVECs was also observed in a time-dependent manner; however, only 10 μmol/L RHL could significantly promote HUVEC proliferation ( Figure 1A, 1B) . In the following study, RHL (5 and 10 μmol/L) enhanced Sirt1 transcription and expression in a dose-dependent manner compared to the vehicle (Figure 2 ).
Establishing senescence model in HUVECs and Sirt1 can delay HUVEC cellular senescence progress
To investigate the effect of Sirt1 on senescence in HUVECs, we first established the senescence model in HUVECs. Four main groups were respectively treated with 0, 25, 50, or 100 µmol/L H 2 O 2 , and senescent cells were found to increase with Figure 3A) ; however, the expression of Sirt1 decreased ( Figure 4A ). In the meantime, we also observed that the number of senescent cells increased with increasing cell passage ( Figure 3B ), and the expression of Sirt1 decreased ( Figure 4B ). Furthermore, 10 µmol/L RHL could antagonize cell senescence induced by H 2 O 2 and the increased passage of HUVECs ( Figure 3C, 3D) ; moreover, siRNA (Sirt1) antagonized the effect of RHL ( Figure 3E, 3F) .
RHL has no effect on the apoptosis signaling pathway (Table 2 ). H 2 O 2 100 µmol/L induced the p53 acetylation and p16 INK4a up-regulation and treatment with 10 µmol/L RHL prevented this process ( Figure  5B ).
Discussion
In our previous study, we found that high concentrations of RHL (more than 20 µmol/L) could inhibit cell proliferation in a dose-dependent manner [12] . In the meantime, we also found that low concentrations of RHL (less than 20 µmol/L) could improve cell proliferation and alleviate the cytotoxicity induced by Taxol (data was not shown). However, how RHL improves cell proliferation is unclear. In this study, we also observed that RHL improved HUVEC proliferation at low concentrations (less than 20 µmol/L), especially at 10 µmol/L ( Figure 1) . As is well known, increased cellular senescence is associated with decreased cell proliferation in vivo because senescent cells cannot divide [16] . Therefore, it can be concluded that by delaying cell senescence, low concentrations of RHL can improve HUVEC proliferation.
Cellular senescence is a process by which cells irreversibly exit the cell cycle and cease to divide in response to a variety of stresses, including oxidative stress [17] . It was reported that oxidative stress damages DNA, leading to activation of the tumor suppressor p53, a key regulator of the cell cycle and cellular senescence. It has also been reported that p53 acetylation promotes expression of growth-suppressive genes and induces cellular senescence [18, 19] . In this study, we established the cell senescence model using H 2 O 2 -treated HUVECs. We found that H 2 O 2 could induce HUVEC senescence in a dosedependent manner ( Figure 3A) . We also found cell spontaneous senescence appeared with an increase in cell passage ( Figure 3B ), and that HUVECs could only survive to the fifth generation without epidermal growth factor (EGF) supplementation. The characteristics of HUVECs made it easier to establish this model of cell senescence. As we investigated the HUVEC senescence mechanism, we observed that the expression of Sirt1 decreased in a dose-dependent manner following treatment with various concentrations of H 2 O 2 , that the expression of Sirt1 decreased with the increase in cell passage ( Figure  4) , and that 10 µmol/L RHL could antagonize cell senescence induced by H 2 O 2 and the increase in the passage of HUVECs ( Figure 3C, 3D) ; moreover, siRNA (Sirt1) could antagonize the effect of RHL ( Figure 3E, 3F) . Therefore, it can be concluded that RHL prevented cellular senescence induced by H 2 O 2 treatment, as well as the increase of cell passage, through enhancing Sirt1 expression ( Figure 3C-3F) .
Endothelial senescence causes endothelial dysfunction, promotes atherogenesis and contributes to age-related vascular disorders. Sirt1 is a key sensor system for regulating endothelial cell survival, proliferation, and senescence. The protective activities of Sirt1 may be achieved at least in part by fine tuning the acetylation/deacetylation of key proteins [20] . In this study, we also observed that the p53 acetylation level was inversely related to the expression of Sirt1 in H 2 O 2 -induced 
